USDA biotech regulations on “Pharma” crops allow drugs in food
Date:
Source: www.current.com


Abstract:

U. S. Department of Agriculture’s newly proposed rule governing genetically engineered crops, including food crops engineered to produce pharmaceutical and industrial products came under severe opposition by the Union of concerned scientists. The charge is that the rule does not protect the U. S. food supply from contamination by drugs from “pharma” crops. There seems to be a contamination by way of cross-pollination or seed mixing between pharma food crops and crops intended for consumption.

Recommendations from various like minded organizations such as UCS and Grocery Manufacturers Association to ban outdoor production of pharma food crops have been ignored by USDA. The new proposal also does not offer any incentives for pharma companies to follow already existing safer methods of producing drugs.

USDA has also left a very small window for public participation in its rush to enact this rule into law. 

 

Click here for Detail Description
Bookmark and Share
Compliance Trainings
Understanding Disinfectant Qualification Studies – How to avoid errors
On Demand Access Anytime
Performing Investigations for Environmental Excursions
On Demand Access Anytime
Environmental Monitoring and the Contamination Control Plan
On Demand Access Anytime
How to Investigate Water System Contamination with Example Case Studies
On Demand Access Anytime
more...
Contributing Authors/ Experts
Maik Jornitz, Group Vice President Marketing, Sartorius Stedim Biotech, Inc.
Jeff Odum, gjgjg, NCBioSource
Scott Sutton, Director, Vectech Pharmaceutical Consultants
Compliance Standards
Validation Master Plan
Price: $90
Method Validation
Price: $79
QVD Protocol and Report Preparation
Price: $99
Monitoring of Clinical Trials
Price: $29
More Standards...